How it works
Fragment-based lead discovery is an innovative drug discovery process that identifies small chemical fragments capable of binding to a target protein. Unlike traditional methods that focus on a few large, complex compounds, this approach explores a broader chemical space relevant to the drug targets of interest. The process involves screening a library of small fragments to find those that bind, even if weakly, to the target protein. Once identified, these fragments serve as starting points for further optimisation and development into more potent lead compounds.
This method increases the likelihood of finding effective drug candidates by providing high-throughput screening of a range of chemical space that is efficient and cost-effective. Additionally, it can be combined with other research techniques to yield even deeper insights.
